Mechanistic aspects of the cytotoxic activity of glufosfamide, a new tumour therapeutic agent

British Journal of Cancer

Volumn 82, Issue 3, 2000, Pages 629-634

  Seker, H ^a   Bertram, B ^a   Burkle A ^a   Kaina, B ^b   Pohl, J ^c   Koepsell, H ^d   Wiessler M ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c ASTA MEDICA AG   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

DNA repair deficiency; Poly(ADP ribose) polymerase; Tumour therapy; D glucosyl ifosfamide mustard

Indexed keywords

ANTINEOPLASTIC AGENT; IFOSFAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL STRAIN V 79; CELL SURVIVAL; CHO CELL; CYTOTOXICITY TEST; DNA CROSS LINKING; DNA SYNTHESIS; ENZYME ACTIVATION; GENOTOXICITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

EID: 0033975038     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0974     Document Type: Article

References (17)

1. Bürkle A, Chen G. Küpper J-H, Grube K and Zeller WJ (1993) Increased poly(ADP-ribosyl)ation in intact cells by cisplatin treatment. Carcinogenesis 14: 559-561
2. De Murcia G and Ménissier-de Murcia J (1994) Poly(ADP-ribose) polymerase: a molecular nick sensor. Trends Biochem Sci 19: 172-176
3. Dickes M (1988) Synthese und Untersuchungen zur Stabilität und biologischen Aktiviatät O-glykosidisch gekoppelter 2-Chlorethyl-phosphorsäurediamideeiner neuen Klasse antineoplastisch wirksamer Alkylantien. PhD thesis, University of Heidelberg
4. Hemminki K, (1986) Reactions of Nitrogen Mustard with DNA. IARC Scientific Publication 78, pp. 55-70. IARC: Lyon
5. 6-methylguanine-DNA methyltransferase (MGMT) CDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents. Carcinogenesis 12: 1857-1867
6. Kawamitsu H, Hoshimo H, Okada H, Miwa M and Sugimura T (1984) Monoclonal antibodies to poly(adenosine diphosphate ribose) recognize different structures. Biochemistry 23: 3771-3777
7. Lindahl T, Satoh MS, Poirier GG and Klungland A (1995) Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem Sci 20: 405-411
8. Monks A, Scuderio DA, Johnsson DS, Paull KD and Sausville EA (1997) The NCI-anti-cancer screen: a smart screen to identify effectors of novel targets. Anti Cancer Drug Design 12: 533-541
9. Oei SL, Griesenbeck J and Schweiger M (1997) The role of poly ADP-ribosylation. Rev Physiol Biochem Pharmacol 131: 4135-4137
10. Pfuhler S and Wolf HU (1996) Detection of DNA-crosslinking agents with the alkaline comet assay. Environment Mol Mutag 27: 196-201
11. Pohl J, Bertram B, Hilgard P, Nowrousian MR, Stüben J and Wießler M (1995) D-19575 - a sugar-linked isophosphoramide mustard derivative exploiting transmembrane glucose transport. Cancer Chemothe. Pharmacol 35: 364-370
12. Seker H, Bertram B and Wießler M (1996) Possible role of the cytosolic β-glucusidase in the metabolism of saccharide-coupled platinum and ifosfamide mustard in tumor cells. In '10th Mediterranean Congress of Chemotherapy' Berkarda, B. (ed.), pp 381-385, Monduzzi Editore
13. Shaw IC, Graham MI (1987) Mesna - a short review. Cancer Treatment Rev 14: 67-86
14. 3H methyl]-thymidine in various tissues of the rat. Cancer Chemother Pharmacol 38: 355-365
15. Tellemann P, Overkamp WJI, van Wessel N, Studzian K, Wetselaar L, Natarajan AT and Zdienicka MZ (1995) A new complementation group of mitomycin C-hypersensitive Chinese hamster cell mutants that closely resembles the phenotype of Fanconi anemia cells. Cancer Res 55: 3412-3416
16. +-D-glucose cotransporter SAATI. Proc Natl Acad Sci USA 95: 2914-2919
17. Workman P (1997) Towards intelligent anticancer drug screening in the post-genuine era? Anti-Cancer Drug Design 12: 525-531